Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression

Table 1

Patient characteristics.

	NYHA class
	<IV	IV
Age (years)	44.2 ± 14.2	43.5 ± 13.9
Sex
Female	4	1
Male	15	5
BMI (kg/m^2)	24.7 ± 4.7	28.7 ± 5.1
NYHA class
II	1
III	16
III-IV	2
IV		6
BNP (pg/mL)	1259 ± 1180	1964 ± 1177
TnT (pg/mL)	80.9 ± 143.5	34.4 ± 13.9
Adiponectin (μg/mL)	22.9 ± 12.6	33.8 ± 17.5
LVEF (%)	24.1 ± 7.4	20.1 ± 6.2
LVESD (mm)	58.2 ± 9.9	64.3 ± 10.2
LVEDD (mm)	67.3 ± 7.4	71.1 ± 12
RAP (mmHg)	12.5 ± 7.3	16.2 ± 11
PAP (mmHg)	32.2 ± 12.1	43.2 ± 15.8
PCWP (mmHg)	23 ± 9.1	31.8 ± 14.2
PVR (Wood units)	2.5 ± 1.7	3.2 ± 0.8
E wave (m/s)	0.9 ± 0.2	1 ± 0.3
A wave (m/s)	0.5 ± 0.2	0.4 ± 0.1
E/A	1.8 ± 1.1	2.3 ± 0.4
E wave (ms)	140.1 ± 35.2	109 ± 45.4